Trial Summary
What is the purpose of this trial?
This study is to test the Multiplo Complete Syphilis (TP/nTP) Antibody Test for its performance in an urban STI clinic using finger-prick obtained whole blood to perform the POCT at the clinic.
Research Team
PO
Patrick O'Byrne, PhD
Principal Investigator
Sexual Health Clinic
Eligibility Criteria
This clinical trial is for individuals visiting a sexual health clinic in Ottawa who may have syphilis. The study aims to include participants from this specific urban population without any further specified inclusion or exclusion criteria provided.Inclusion Criteria
I am following up at the clinic after being diagnosed with syphilis.
Able to provide consent
Patients Requiring Syphilis testing as part of care plan
See 2 more
Exclusion Criteria
I am able to understand and consent to my treatment.
I am under 16 years old.
Treatment Details
Interventions
- Multiplo Complete Syphilis (TP/nTP) Antibody Test (Monoclonal Antibodies)
Trial OverviewThe trial is evaluating the Multiplo Complete Syphilis (TP/nTP) Antibody Test, which uses a finger-prick blood sample to quickly diagnose syphilis at the point of care within the clinic setting.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Experimental Diagnostic: Multiplo Complete Syphilis (TP/nTP) Antibody TestExperimental Treatment1 Intervention
Subjects are tested with investigational devices and conventional syphilis serology tests.
Find a Clinic Near You
Who Is Running the Clinical Trial?
MedMira Laboratories Inc.
Lead Sponsor
Trials
5
Recruited
3,800+